Procurement Summary
Country: Slovakia
Summary: Burosumab Reference Chisel: 27-vo/2023/rdfn
Deadline: 09 Oct 2023
Posting Date: 13 Sep 2023
Other Information
Notice Type: Tender
TOT Ref.No.: 88805799
Document Ref. No.: 31026 - MST
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: EUR 985177.20
CPV Classification
33632000 - Medicinal products for the musculo-skeletal system
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The subject of the order is a medicine with the operative barosumab, known as Cryysvita (hereinafter referred to as the product), for pediatric patients with x-tied form of hypophosphatemic rachitides in the fulfillment of all the lower criteria:
1) with a documented high serum concentration FGF-23
2) with a genetically confirmed mutation in PHEX gene
3) Persistence of low pituitary pituitary, despite the long -term substitution of maximal tolerated phosphate solutions and active form of vitamin D
4) In the progression of bone deformity despite the administration of maximal tolerated doses of standard treatment (phosphate and vitamin D).
Main CPV code: 33632000-9 Main CPV code, additional dictionary: EA26-0-for LA31-3 patients-for child medicine
Additional CPV codes:
60000000-8
Time period: 09.10.2023 08:00
Estimated value:- 985 177, 20 EUR without VAT
Documents
Tender Notice